These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
82 related articles for article (PubMed ID: 7844452)
21. Serum N-terminal osteocalcin is a good indicator for estimating responders to hormone replacement therapy in postmenopausal women. Chen JT; Hosoda K; Hasumi K; Ogata E; Shiraki M J Bone Miner Res; 1996 Nov; 11(11):1784-92. PubMed ID: 8915787 [TBL] [Abstract][Full Text] [Related]
22. A slightly suppressive dose of L-thyroxine does not affect bone turnover and bone mineral density in pre- and postmenopausal women with nontoxic goitre. De Rosa G; Testa A; Maussier ML; Callà C; Astazi P; Albanese C Horm Metab Res; 1995 Nov; 27(11):503-7. PubMed ID: 8770627 [TBL] [Abstract][Full Text] [Related]
23. Relationship of bone turnover to bone density and fractures. Melton LJ; Khosla S; Atkinson EJ; O'Fallon WM; Riggs BL J Bone Miner Res; 1997 Jul; 12(7):1083-91. PubMed ID: 9200008 [TBL] [Abstract][Full Text] [Related]
24. Serum insulin/like growth factor I, bone mineral density and biochemical markers of bone metabolism in children with idiopathic osteoporosis. Chlebna-Sokol D; Rusinska A Endocr Regul; 2001 Dec; 35(4):201-8. PubMed ID: 11858767 [TBL] [Abstract][Full Text] [Related]
25. [Age-related and menopause-related changes of urinary excretion of C- and N-terminal cross-linked telopeptides of type I collagen and the relationships thereof with menopause-related bone loss]. Liu SP; Liao EY; Wu XP; Cao XZ; Shan PF; Su X Zhonghua Yi Xue Za Zhi; 2006 Feb; 86(6):371-5. PubMed ID: 16677543 [TBL] [Abstract][Full Text] [Related]
26. [Influences of menopause and oophorectomy on bone metabolism and spinal bone mineral content]. Ohta H; Suda Y; Makita K; Nozawa S; Nemoto K Nihon Sanka Fujinka Gakkai Zasshi; 1991 Apr; 43(4):422-8. PubMed ID: 2066615 [TBL] [Abstract][Full Text] [Related]
27. The acute effects of exercise on bone turnover. Welsh L; Rutherford OM; James I; Crowley C; Comer M; Wolman R Int J Sports Med; 1997 May; 18(4):247-51. PubMed ID: 9231839 [TBL] [Abstract][Full Text] [Related]
28. Effect of vitamin K2 treatment on carboxylation of osteocalcin in early postmenopausal women. Yasui T; Miyatani Y; Tomita J; Yamada M; Uemura H; Miura M; Irahara M Gynecol Endocrinol; 2006 Aug; 22(8):455-9. PubMed ID: 17012108 [TBL] [Abstract][Full Text] [Related]
29. A longitudinal study of bone-related biochemical changes at the menopause. Nordin BE; WIshart JM; Clifton PM; McArthur R; Scopacasa F; Need AG; Morris HA; O'Loughlin PD; Horowitz M Clin Endocrinol (Oxf); 2004 Jul; 61(1):123-30. PubMed ID: 15212654 [TBL] [Abstract][Full Text] [Related]
30. Comparison of biochemical markers of bone turnover and bone mineral density in different groups of climacteric women. Morgante G; La Marca A; Ditto A; Musacchio MC; Cavicchioli C; Lanzetta D; Petraglia F; De Leo V Gynecol Endocrinol; 2001 Dec; 15(6):466-71. PubMed ID: 11826771 [TBL] [Abstract][Full Text] [Related]
31. The long-term effect of menopause on postmenopausal bone loss in Japanese women: results from a prospective study. Okano H; Mizunuma H; Soda M; Kagami I; Miyamoto S; Ohsawa M; Ibuki Y; Shiraki M; Suzuki T; Shibata H J Bone Miner Res; 1998 Feb; 13(2):303-9. PubMed ID: 9495525 [TBL] [Abstract][Full Text] [Related]
32. A single measurement of biochemical markers of bone turnover has limited utility in the individual person. Beck-Jensen JE; Kollerup G; Sørensen HA; Pors Nielsen S; Sørensen OH Scand J Clin Lab Invest; 1997 Jul; 57(4):351-9. PubMed ID: 9249882 [TBL] [Abstract][Full Text] [Related]
33. Metabolic markers for the early diagnosis of postmenopausal osteoporosis. Isaia G; Mussetta M; Di Stefano M; Sciolla A; Triolo S; Molinatti GM J Endocrinol Invest; 1994 Nov; 17(10):771-4. PubMed ID: 7699209 [TBL] [Abstract][Full Text] [Related]
34. Age and menopause-related changes in indices of bone turnover. Kelly PJ; Pocock NA; Sambrook PN; Eisman JA J Clin Endocrinol Metab; 1989 Dec; 69(6):1160-5. PubMed ID: 2511220 [TBL] [Abstract][Full Text] [Related]
35. Changes of biochemical bone markers during the menopausal transition. Rosenbrock H; Seifert-Klauss V; Kaspar S; Busch R; Luppa PB Clin Chem Lab Med; 2002 Feb; 40(2):143-51. PubMed ID: 11939487 [TBL] [Abstract][Full Text] [Related]
36. Racial differences in pre- and postmenopausal bone homeostasis: association with bone density. Meier DE; Luckey MM; Wallenstein S; Lapinski RH; Catherwood B J Bone Miner Res; 1992 Oct; 7(10):1181-9. PubMed ID: 1456086 [TBL] [Abstract][Full Text] [Related]
37. The effect of menopause on biochemical markers and ultrasound densitometry in healthy females. Kawana K; Kushida K; Takahashi M; Ohishi T; Denda M; Yamazaki K; Inoue T Calcif Tissue Int; 1994 Dec; 55(6):420-5. PubMed ID: 7895180 [TBL] [Abstract][Full Text] [Related]
38. Biochemical measurements in the prediction of histologic subtype of renal transplant bone disease in women. Parker CR; Blackwell PJ; Freemont AJ; Hosking DJ Am J Kidney Dis; 2002 Aug; 40(2):385-96. PubMed ID: 12148113 [TBL] [Abstract][Full Text] [Related]
39. [Biological markers of bone metabolism]. Delmas PD Presse Med; 1993 Feb; 22(6):263-8. PubMed ID: 8511145 [TBL] [Abstract][Full Text] [Related]
40. Aminohexane bisphosphonate suppresses bone turnover in postmenopausal women more rapidly than oestrogen-gestagen therapy. Tobias JH; Laversuch CJ; Chambers TJ; Gallagher AC Br J Rheumatol; 1996 Jul; 35(7):636-41. PubMed ID: 8670596 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]